$3.20
9.49% day before yesterday
Nasdaq, Nov 14, 03:30 pm CET
ISIN
US28658R1068
Symbol
ELYM
Sector
Industry

Eliem Therapeutics Inc Target price 2024 - Analyst rating & recommendation

Eliem Therapeutics Inc Classifications & Recommendation:

Hold
100%

Eliem Therapeutics Inc Price Target

Target Price $4.50
Price $3.01
Potential
Number of Estimates 2
2 Analysts have issued a price target Eliem Therapeutics Inc 2025 . The average Eliem Therapeutics Inc target price is $4.50. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 1 analysts: 0 Analysts recommend Eliem Therapeutics Inc to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Eliem Therapeutics Inc stock has an average upside potential 2025 of . Most analysts recommend the Eliem Therapeutics Inc stock at Hold.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today